Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by ConcertAI

ConcertAI Appoints Dr. Shaalan Beg as Chief Medical Officer, Oncology
From ConcertAI
Via Business Wire
ConcertAI’s TeraRecon Surpasses 2,000 Global Customers, Accelerating Cloud-First SaaS Transformation to Further Unlock Productivity for Healthcare Providers
From ConcertAI
Via Business Wire
Casey Graves Joins ConcertAI as General Manager, Clinical Solutions
From ConcertAI
Via Business Wire
CancerLinQ Receives ASCO Certified™ RQS Recognition Enabling Automated Quality Tracking That Helps Oncology Care Practices Save Critical Time and Resources
From ConcertAI
Via Business Wire
ConcertAI Appoints Michael Myshrall as Chief Financial Officer
From ConcertAI
Via Business Wire
ConcertAI Provides Intelligent Automation of ASCO® Guidelines into its Generative and Agentic AI Precision Suite™ and CancerLinQ® SmartLinQ™ Solutions
From ConcertAI
Via Business Wire
ConcertAI Launches New Generative and Agentic AI-Powered Precision Suite™ Accelerating Oncology Insights and Actions for Healthcare and Life Sciences
From ConcertAI
Via Business Wire
ConcertAI Announces Leadership Transition to Accelerate AI Innovation and Growth
From ConcertAI
Via Business Wire
ConcertAI Announces Strategic Agreement with Bayer to Accelerate Clinical Development in Precision Oncology
From ConcertAI
Via Business Wire
ConcertAI Announces Strategic Agreement with Bayer to Accelerate Clinical Development in Precision Oncology
From ConcertAI
Via Business Wire
EY US unveils Jeff Elton of ConcertAI as an Entrepreneur Of The Year® 2025 New England Award finalist
From ConcertAI
Via Business Wire
ConcertAI’s TeraRecon and 3DR Labs Announce Expanded Partnership to Transform the Delivery of AI-Enabled Image Post Processing Clinical Services for US Healthcare Providers
From ConcertAI
Via Business Wire
ConcertAI presents CARAai Multi-LLM and Agentic AI for Clinical Development and Insights at NVIDIA GTC 2025
From ConcertAI
Via Business Wire
At SCOPE 2025, ConcertAI Announces Major Advances in Trial Technologies for Research Sites and Sponsors
From ConcertAI
Via Business Wire
Exigent Research, Leading National Community Research Network, Partners with AI Leader ConcertAI to Integrate CARAai™ Precision Trial Solutions
From ConcertAI
Via Business Wire
ConcertAI Presents at 43rd Annual J.P. Morgan Healthcare Conference: 2024 Results and 2025-2028 AI Solutions Roadmap
From ConcertAI
Via Business Wire
ConcertAI and NeoGenomics Announce New AI Software-as-a-Service Solution for Hematology Clinical Research
From ConcertAI
Via Business Wire
ConcertAI Announces Cloud-Based SaaS Transformation of TeraRecon Portfolio, Expanding its AI-Enhanced Clinical Capabilities in Medical Imaging
From ConcertAI
Via Business Wire
TeraRecon’s New Intuition Product Line Delivers AI Productivity and Industry-leading Cardiac MR Workflows, All Delivered Through a Robust Software-as-a-Service (SaaS) Platform
From ConcertAI
Via Business Wire
ConcertAI Appoints James Salitan as General Counsel
From ConcertAI
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.